Literature DB >> 7532540

The effects of bisphosphonates on the resorption cycle of isolated osteoclasts.

K Selander1, P Lehenkari, H K Väänänen.   

Abstract

Binding sites for wheat germ agglutinin (WGA)-lectin have been shown to become revealed in the demineralized resorption lacunae that osteoclasts excavate on bone substrate. Peroxidase-conjugated WGA-lectin, which binds to bone matrix glycoconjugates and proteoglycans, was used in pit formation assays to assess the activity of isolated osteoclasts cultured on either 3-amino-1,1-hydroxypropylidene-bisphosphonate (APD)-or dichloromethylene bisphosphonate (Cl2MBP)-covered bone slices. Immunofluorescence and histochemical techniques were also used to study the effects of bone-bound bisphosphonates on isolated rat osteoclasts. Neither APD nor Cl2MBP interfered with the special organization of actin or vinculin in osteoclasts when the cells were initializing their resorption cycle. After 24 hours of culture, the number of resorbing osteoclasts increased strongly on control slices, but remained low on either APD- or Cl2MBP-treated slices. At this time, the actin and vinculin rings in osteoclasts also started to exhibit abnormal, more diffuse staining. Both bisphosphonates studied resulted in signs of cytotoxicity: the number of osteoclasts decreased on APD- or Cl2MBP-covered bone during the course of the study and those remaining attached exhibited severe cytoplasmic retractions. The total areas of resorption remained at significantly lower levels in both experimental groups studied, and this was due to decreases in both the number and sizes of individual resorption pits. The size of the most extensive lacunae detected on the Cl2MBP slices did not exceed 5 x 10(3) microns 2, whereas on the control slices, resorption pits bigger than 15 x 10(3) microns 2 were frequently discovered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532540     DOI: 10.1007/bf00299317

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  38 in total

1.  Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.

Authors:  P T Lakkakorpi; H K Väänänen
Journal:  J Bone Miner Res       Date:  1991-08       Impact factor: 6.741

2.  The alteration of osteoclast morphology by diphosphonates in bone organ culture.

Authors:  E J Rowe; E Hausmann
Journal:  Calcif Tissue Res       Date:  1976-04-13

3.  Osteoclastic bone resorption: in vitro analysis of the rate of resorption and migration of individual osteoclasts.

Authors:  J Kanehisa; J N Heersche
Journal:  Bone       Date:  1988       Impact factor: 4.398

4.  Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia.

Authors:  S H Ralston; S J Gallacher; U Patel; F J Dryburgh; W D Fraser; R A Cowan; I T Boyle
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

5.  Organization of osteoclast microfilaments during the attachment to bone surface in vitro.

Authors:  P Lakkakorpi; J Tuukkanen; T Hentunen; K Järvelin; K Väänänen
Journal:  J Bone Miner Res       Date:  1989-12       Impact factor: 6.741

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Calcitonin, prostaglandin E2, and dibutyryl cyclic adenosine 3',5'-monophosphate disperse the specific microfilament structure in resorbing osteoclasts.

Authors:  P T Lakkakorpi; H K Väänänen
Journal:  J Histochem Cytochem       Date:  1990-10       Impact factor: 2.479

8.  The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat.

Authors:  S C Miller; W S Jee
Journal:  Anat Rec       Date:  1979-03

9.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.

Authors:  P M Boonekamp; L J van der Wee-Pals; M M van Wijk-van Lennep; C W Thesing; O L Bijvoet
Journal:  Bone Miner       Date:  1986-02

10.  Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures.

Authors:  P C Marchisio; D Cirillo; L Naldini; M V Primavera; A Teti; A Zambonin-Zallone
Journal:  J Cell Biol       Date:  1984-11       Impact factor: 10.539

View more
  19 in total

1.  Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies.

Authors:  L Tauchmanovà; C Selleri; M Esposito; C Di Somma; F Orio; G Bifulco; S Palomba; G Lombardi; B Rotoli; A Colao
Journal:  Osteoporos Int       Date:  2003-09-30       Impact factor: 4.507

2.  Improved methods for testing antiresorptive compounds in human osteoclast cultures.

Authors:  Jukka P Rissanen; Hannele Ylipahkala; Katja M Fagerlund; Clive Long; H Kalervo Väänänen; Jussi M Halleen
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

3.  Resorption-cycle-dependent polarization of mRNAs for different subunits of V-ATPase in bone-resorbing osteoclasts.

Authors:  T Laitala-Leinonen; M L Howell; G E Dean; H K Väänänen
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

4.  Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy.

Authors:  Keiko Suzuki; Sadaaki Takeyama; Takashi Kikuchi; Shoji Yamada; Jaro Sodek; Hisashi Shinoda
Journal:  J Histochem Cytochem       Date:  2005-08-08       Impact factor: 2.479

5.  Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.

Authors:  Yukiko Kuroda; Chihiro Hisatsune; Akihiro Mizutani; Naoko Ogawa; Koichi Matsuo; Katsuhiko Mikoshiba
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

6.  Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders.

Authors:  Luigi Sinigaglia; Massimo Varenna; Silvia Casari
Journal:  Clin Cases Miner Bone Metab       Date:  2007-01

7.  Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells.

Authors:  S D Hafeman; D Varland; S W Dow
Journal:  Vet Comp Oncol       Date:  2011-05-18       Impact factor: 2.613

8.  DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway.

Authors:  Keizo Nishikawa; Yoriko Iwamoto; Yasuhiro Kobayashi; Fumiki Katsuoka; Shin-ichi Kawaguchi; Tadayuki Tsujita; Takashi Nakamura; Shigeaki Kato; Masayuki Yamamoto; Hiroshi Takayanagi; Masaru Ishii
Journal:  Nat Med       Date:  2015-02-23       Impact factor: 53.440

9.  Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis.

Authors:  Naoko Irie; Yasunari Takada; Yoshihiko Watanabe; Yumi Matsuzaki; Chie Naruse; Masahide Asano; Yoichiro Iwakura; Toshio Suda; Koichi Matsuo
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

10.  Development of an in vitro culture method for stepwise differentiation of mouse embryonic stem cells and induced pluripotent stem cells into mature osteoclasts.

Authors:  Keizo Nishikawa; Yoriko Iwamoto; Masaru Ishii
Journal:  J Bone Miner Metab       Date:  2013-12-24       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.